Back to the newspaper
DEVELOPING · Attributed source report · science · World

Trial results posted: A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

NULLPEN · Source published 11/19/2026, 12:00:00 AM UTC

ClinicalTrials.gov records the first posting of results for study NCT05348915 on 2026-11-19. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

The source record

National Library of Medicine, National Institutes of Health

Source: ClinicalTrials.gov, National Library of Medicine, United States. Registry entries are filed by trial sponsors; the registry does not verify them.Retrieved 2026-11-19T17:00:25.862Z. Updated on NULLPEN 2026-11-19T17:00:28.725Z.Revision sha256:1de8937c98289ffa8f59c677b51636b3c6823b1c44c3ebf940c3f2fd19b580c8